J3379 is the authoritative medical code for Injection, valproate sodium, 5 mg. This classification is used in medical billing and clinical recording to specify the clinical criteria for injection, valproate sodium, 5 mg (HCPCS Level II J3379), ensuring healthcare documentation aligns with 2026 federal coding standards.
Billing Status: Processed within HCPCS Level II standards. CMS regulatory guidelines apply.
Official Registry Overview & Definition
Injection, valproate sodium, 5 mg is a HCPCS Level II code J3379 for a Medicare-covered supply, service, or procedure. Short description: Inj, valproate sod, 5 mg.
Codes in This Family (37)
Official HCPCS Level II classifications in the same code family as J3379, with their registry titles.
- J3300 — Injection, triamcinolone acetonide, preservative free, 1 mg
- J3301 — Injection, triamcinolone acetonide, not otherwise specified, 10 mg
- J3302 — Injection, triamcinolone diacetate, per 5 mg
- J3303 — Injection, triamcinolone hexacetonide, per 5 mg
- J3304 — Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg
- J3305 — Injection, trimetrexate glucuronate, per 25 mg
- J3310 — Injection, perphenazine, up to 5 mg
- J3315 — Injection, triptorelin pamoate, 3.75 mg
- J3316 — Injection, triptorelin, extended-release, 3.75 mg
- J3320 — Injection, spectinomycin dihydrochloride, up to 2 gm
- J3350 — Injection, urea, up to 40 gm
- J3355 — Injection, urofollitropin, 75 iu
- J3357 — Ustekinumab, for subcutaneous injection, 1 mg
- J3358 — Ustekinumab, for intravenous injection, 1 mg
- J3360 — Injection, diazepam, up to 5 mg
- J3364 — Injection, urokinase, 5000 iu vial
- J3365 — Injection, iv, urokinase, 250,000 i.u. vial
- J3370 — Injection, vancomycin hcl, 500 mg
- J3371 — Injection, vancomycin hcl (mylan), not therapeutically equivalent to j3370, 500 mg
- J3372 — Injection, vancomycin hcl (xellia), not therapeutically equivalent to j3370, 500 mg
- J3373 — Injection, vancomycin hydrochloride, 10 mg
- J3374 — Injection, vancomycin hydrochloride (mylan) not therapeutically equivalent to j3373, 10 mg
- J3375 — Injection, vancomycin hydrochloride (tyzavan), not therapeutically equivalent to j3373, 10 mg
- J3376 — Injection, vancomycin hcl (hikma), not therapeutically equivalent to j3373, 10 mg
- J3380 — Injection, vedolizumab, intravenous, 1 mg
- J3385 — Injection, velaglucerase alfa, 100 units
- J3386 — Injection, etuvetidigene autotemcel, per treatment
- J3387 — Injection, elivaldogene autotemcel, per treatment
- J3389 — Topical administration, prademagene zamikeracel, per treatment
- J3391 — Injection, atidarsagene autotemcel, per treatment
- J3392 — Injection, exagamglogene autotemcel, per treatment
- J3393 — Injection, betibeglogene autotemcel, per treatment
- J3394 — Injection, lovotibeglogene autotemcel, per treatment
- J3396 — Injection, verteporfin, 0.1 mg
- J3397 — Injection, vestronidase alfa-vjbk, 1 mg
- J3398 — Injection, voretigene neparvovec-rzyl, 1 billion vector genomes
- J3399 — Injection, onasemnogene abeparvovec-xioi, per treatment, up to 5x10^15 vector genomes
Related Codes & Numerical Sequence (Crawl Map)
Search engines and indexers are advised to traverse adjacent medical codes in this sub-chapter range to find correlated diagnoses or therapeutic procedures:
HCPCS Code J3374
Injection, vancomycin hydrochloride (mylan) not therapeutically equivalent to j3373, 10 mg
HCPCS Code J3375
Injection, vancomycin hydrochloride (tyzavan), not therapeutically equivalent to j3373, 10 mg
HCPCS Code J3376
Injection, vancomycin hcl (hikma), not therapeutically equivalent to j3373, 10 mg